Compare / TGC vs Venture Capital
Alternatives to venture capital, structured for compounding revenue.
For B2B SaaS founders past product-market fit who want execution capacity alongside capital - without trading control for valuation.
Why founders look for alternatives to venture capital
Venture capital is well suited to a specific moment: a founder who needs capital to find product-market fit and to discover the unit economics that will define the business. The portfolio mechanics demand outsized winners, and the term sheets reflect that - preferences, anti-dilution protections, board control mechanisms that compound across rounds.
What changes after product-market fit is the founder’s problem. The bottleneck is no longer "can we find demand?" - it is "can we ship product, sell to enterprise, and pass procurement before the cash runs out?" That is an operating problem, not a capital problem. Venture capital can fund the runway. It rarely brings the operating capacity that uses the runway.
The structural alternatives
Operator-led growth equity (TGC)
Capital paired with embedded operating teams - full-time engineers, GTM operators, governance specialists deployed under a written operating thesis. Minority equity, founder-friendly terms, no control transactions, no fixed exit window. See the platform for the full mechanic and engagement models for how it sequences against ARR scale.
Late-stage private equity
Typically enters at €5M–€50M ARR with majority or large-minority positions. Returns engineered through multiple expansion, bolt-on M&A, and operating discipline over a 4–6 year hold. Right answer when the founder is ready for control transactions or defined exit timing. See TGC vs private equity for the structural read.
Revenue-based financing
Non-dilutive, revenue-share-style instruments that fit predictable subscription revenue. Useful for working-capital expansion (CAC funding, sales-team investment) without giving up equity. Limited utility when the company needs operating depth as much as cash.
Family-office direct investment
Patient capital with longer time horizons than fund-driven LPs. Increasingly active at growth stage. Strong on capital, variable on operating capacity. The investment criteria most family offices use closely resemble PE diligence; we cover this in family-office PE investment criteria.
Corporate strategic capital
Capital from a corporate investor with strategic angle (distribution, integration, market access). Powerful when the corporate is genuinely a customer or distribution partner. Risk: optionality on competitive moves, restrictive change-of-control rights.
When venture capital is still the right call
Three cases:
- Pre-product-market-fit. If the company is still discovering whether the product solves a real problem at scale, venture capital is the right risk capital. Operating capacity does not solve the demand-discovery problem.
- Winner-takes-most market dynamics. If the category genuinely rewards the first scaled mover and that means burning faster than economics support for 18 months, venture capital’s portfolio expectations align with that bet.
- Deep-tech or long-research-window companies. Multi-year R&D risks before commercial launch are venture territory, not growth-equity territory.
If the company is past product-market fit and the next 24 months are about ship-velocity, sales-execution, and compounding revenue without losing control through dilution - that’s what TGC is structured for.
How TGC and venture capital can co-exist on a cap table
Most TGC partnerships involve companies that have already raised seed or Series A from venture investors. The two instruments are complements, not substitutes, when the company has crossed into the scale phase:
- Existing VC investors keep their economics and pro-rata rights.
- TGC enters at the next round (or a primary-secondary mix) with founder-friendly conventions and embedded operating capacity.
- Board composition reflects the new economic shape but stays proportionate to ownership, not weighted toward the latest investor.
- The operating thesis is co-developed with the founder, board, and existing investors so that the deployed capacity solves real operating gaps rather than duplicating advisor relationships.
This is a routine pattern, not an exception.
Comparative term sheets: venture capital vs operator-led growth equity
Term-sheet defaults differ in patterned ways at the €1M–€5M ARR scale. Both sides negotiate around these starting points; the value of the comparison is the starting point itself.
| Term | Growth-stage VC (Series B+) | TGC (operator-led growth equity) |
|---|---|---|
| Stage focus | Pre-PMF through Series A; some Series B | Post-PMF, €0.5M–€10M ARR |
| Position | Minority (10–25% per round, compounding across rounds) | Minority (10–25%, single-round structure) |
| Liquidation preference | 1× non-participating standard; 1.5× or participating appears in down-cycle markets | 1× non-participating only |
| Anti-dilution | Broad-based weighted-average standard; full ratchet appears in tougher rounds | Broad-based weighted-average; full ratchet refused |
| Board composition | Investor seat per round; can stack to majority across rounds | Proportionate to ownership; no minority veto on operating decisions |
| Protective provisions | Standard VC list (sale, financing, budget, key hires) | Limited to fundamental governance items; founder retains operating and hiring authority |
| Operating capacity included | Capital plus board seat; platform services and operating partners on a quarterly cadence | Capital plus 8–25 embedded operators on a written 12–24 month deployment |
| Time horizon | Fund cycle 8–10 years; pressure to mark in year 3–5 | Open-ended; inflection-event driven |
| Pro-rata expectation | Strong; failing to participate signals trouble | Held but not forcing - round-by-round decision |
| Exit pressure | Material from year 3 onward | None imposed; founder leads the exit conversation |
How venture capitalists evaluate B2B SaaS at this stage
The VC diligence frame at €1M–€5M ARR is consistent across firms. Three lenses dominate:
Market and category dynamics
VCs price the size of the addressable market and the category’s shape. Winner-takes-most categories are valued at premium multiples because the portfolio expectation is a few outsized winners. Steady-share categories (where multiple companies can compound at moderate margins) read as growth-equity territory in the VC’s own framing - they will invest but expect the company to either sell into a larger platform or graduate to growth equity within two rounds.
Growth velocity and revenue durability
The standard VC pattern at €3M ARR: 80–150% annual growth, NRR > 115%, gross margins > 70%, capital efficiency that allows the company to be defensible without a massive Series C raise. A €3M ARR company growing 50% with 105% NRR is valued by VCs at a discount to a €2M ARR company growing 120% with 130% NRR - the latter signals winner-takes-most dynamics.
Founder-market fit and team quality
The most subjective and most weighted input. VCs lean heavily on founder track record, founding team composition, and the team’s ability to recruit world-class hires. A first-time founder with strong recent venture-backed traction can outweigh stronger unit economics from a less-credentialed team. For the analytical frame on how PE firms value the same companies one notch later, see how PE firms value SaaS.
The dilution math at €3M ARR: VC vs operator-led
The single most concrete comparison is what the founder owns at exit. The math depends on assumptions about future rounds but the pattern repeats across well-modelled deals.
Path A - VC track: €3M ARR company raises €10M Series B at €40M post (20% dilution per round assumed). Reaches €10M ARR, raises €25M Series C at €120M post (additional 17% dilution). Reaches €25M ARR, raises Series D or exits to PE at €350M. Founder starts at ~60% post-seed, ends at ~33% pre-exit after stacking dilutions. Standard pattern; not pessimistic.
Path B - operator-led track: €3M ARR company raises €5M from TGC at €25M post (17% dilution), receives 8–25 embedded operators alongside capital. Reaches €10M ARR with the operating capacity delivered rather than re-hired (~30–40% less total capital required because the operating gap is filled). May raise a Series C from institutional VC at higher valuation given the operating maturity (~12% additional dilution). Reaches €25M ARR at exit. Founder starts at ~60%, ends at ~45% pre-exit because the early-stage capital efficiency means fewer rounds and less compounded dilution.
The math is not magic; it is arithmetic over a different capital structure. The €5M difference in retained ownership at a €350M exit is €17.5M of incremental founder proceeds. The compound effect of bundled operating capacity is what produces that gap. For the underlying scaling thesis see scaling SaaS from €1M to €10M ARR.
What founders typically get wrong about venture capital alternatives
- Treating "alternative" as a one-bucket label. Growth equity, family-office direct, revenue-based financing, corporate strategic, secondaries - these are all called "alternatives to venture capital" but they are structurally as different from each other as VC is from any of them. The right comparison for a B2B SaaS founder past PMF is rarely VC-vs-everything; it is VC-vs-operator-led-growth-equity-vs-private-equity, with the others ruled out by stage or strategy.
- Optimising for headline valuation. A €4M raise at €30M from VC is not better than a €4M raise at €25M from TGC if the second includes €3M–€5M of embedded operating capacity over 18 months. The founder’s effective equity cost depends on how much the operating capacity would have cost to build internally, not just dilution per euro raised.
- Underestimating the cap-table compounding of VC term sheets. One Series B at standard VC terms is benign. Stacking Series B + C + D at the same terms creates a control structure that progressively narrows the founder’s authority over strategic decisions. The "alternative to VC" question is sometimes really "do I want this control trajectory?"
- Choosing on personality, not structure. Founders frequently choose investors based on the lead partner’s personal style. That matters, but it is a poor selector for structural fit. A great VC partner running a power-law portfolio still has to behave like a power-law-portfolio investor when the company plateaus. The structure dominates the personality over the life of the partnership.
When operator-led growth equity is the wrong answer
To be honest about it: operator-led growth equity is not always the right call. Specifically:
- Pre-product-market-fit. The deployed operating capacity does not solve the demand-discovery problem. If the company is still validating whether the product fits a real market, venture capital’s risk-tolerance and patience for iteration is the right capital.
- Winner-takes-most timing pressure. If the category genuinely rewards the first scaled mover and the next 12–18 months are about market-share capture before alternatives consolidate, a VC’s burn tolerance and follow-on capacity matter more than embedded operating bench.
- Strong existing operating bench. If the company has already built a senior leadership team (CTO, CRO, CFO all in place and ramped), the marginal value of additional embedded operators drops. In this case capital alone may be the right ask, and growth-stage VC or growth-equity PE is the structural match.
Frequently asked questions
- What are the alternatives to venture capital for scaling a private B2B SaaS company?
- The realistic alternatives are: (1) growth equity from operator-led firms like TGC; (2) private equity at €5M+ ARR for control transactions; (3) revenue-based financing for predictable subscription revenue; (4) family office direct investment; (5) corporate strategic capital. Each has structurally different terms, time horizons, and operational involvement. For founders past product-market fit who want to retain control and add operating capacity, operator-led growth equity is usually the cleanest fit.
- How is venture capital structurally different from operator-led growth equity?
- Venture capital deploys capital with limited day-to-day operating involvement. Returns depend on a small fraction of portfolio companies generating power-law outcomes. The portfolio model demands aggressive growth bets and frequently requires founders to optimise for valuation in the next round rather than fundamental unit economics. Operator-led growth equity inverts that: minority capital paired with embedded operating teams (engineers, GTM operators, governance), structured around revenue compounding and capital efficiency.
- Is operator-led growth equity always better than venture capital?
- No. Pre-product-market-fit companies, deep-tech with long technical risk windows, and companies whose value-creation thesis genuinely depends on capturing a winner-takes-most market within 24 months - these are venture capital territory. Operator-led growth equity is the right instrument for companies that have product-market fit and need execution capacity to compound revenue without losing control through dilution.
- What are venture capital alternative investments?
- In the institutional language used by family offices and LPs, "venture capital alternatives" often refers to: growth equity, late-stage private equity, secondary funds, search funds, revenue-based financing, and direct investments through operating partnerships. From the founder side the question is simpler - what funding instrument fits the company's stage, retains the right amount of control, and bundles the operating capacity the company needs.
- How does TGC compare on time horizon to venture capital?
- Venture funds typically deploy capital over a 3-year investment period and aim for fund-level liquidity over 8–10 years. Pressure to mark to next round dominates the middle period. TGC has no fixed hold horizon. Many partnerships extend beyond a typical VC fund cycle. Returns compound through revenue and operating leverage rather than valuation step-ups.
- Will TGC participate alongside an existing VC investor in my company?
- Yes, and routinely. Many TGC partnerships involve companies that have already raised seed or Series A from venture investors and need execution capacity to reach the next milestone. We co-exist comfortably with venture cap-table participants when the operating thesis is clear and term-sheet conventions remain founder-friendly.
- What is the difference between venture capital and private equity?
- Venture capital invests in early-stage companies (often pre-revenue or pre-product-market-fit) with a power-law portfolio expectation. Private equity invests in established companies (typically €5M+ ARR or equivalent EBITDA) with control or significant minority positions and uses leverage and operating discipline to engineer returns. They are different stages, different ownership structures, and different return models. The companion comparison TGC vs private equity covers the PE side in detail.
Related reading: TGC vs Private Equity · TGC vs Venture Studios · Operator-led vs traditional investors